Medical and Science
NSW funding to tackle 3,000 extra emergency visits per 1% drop in bulk billing
Medical: An Australian-first move aims to encourage GPs to bulk bill and ease pressure on public hospitals.
The NSW government has budgeted $189m to give rebates to GP clinics that bulk bill for most patients while axing historical payroll tax issues.
Under the new scheme, clinics that meet a bulk-billing threshold of 80% in Sydney and 70% in the rest of the state will receive a payroll tax rebate for contractor GPs.
As it stands, payroll tax has not been collected from GP clinics due to a moratorium implemented by the state government until September 4. It’s expected the rebate will stop GP practices from passing on payroll tax costs to patients while also reducing pressure on public hospital emergency departments.
NSW Health data estimates that a 1% decrease in bulk billing equates to about an extra 3000 emergency department presentations.
The government will introduce legislation to enact the rebate and waive past unpaid payroll tax liability for contractor GPs that’s incurred up until September 4. Industry bodies had warned that historical tax debts could result in GPs closing shop or increasing the cost of GP appointments by as much as $20 per visit.
NSW Finance Minister Courtney Houssos said the policy would act “in concert” with the federal government’s $1.5bn measure to ensure GPs receive 34 per cent more for standard bulk-billed consultations that came into affect late last year.
“We want to be able to support our GPs who are providing bulk-billing services,” she said.
“The previous budget from the federal Labor government has increased bulk-billing rebates, but they only started to flow to doctors in November last year. We expect that over time, they will continue to have effect and hopefully we will see increases in bulk billing.”
However, NSW Opposition Leader Mark Speakman questioned whether the proposed rebates would increase bulk-billed appointments, as payroll tax to date had never been enforced on GPs.
While he welcomed the policy, he said it didn’t represent “cost-of-living relief”.
“It will not make GP visits cheaper. It just won’t increase the cost of going to a GP, which might otherwise have been the case if the payroll tax had been enforced,” he said.
Despite this, peak bodies including the Australian Medical Association (AMA) and the Royal Australian College of General Practioners (RACGP) welcomed the changes.
“Legislating ‘no retrospectivity’ will provide certainty for practices and will minimise the risk of more closures of general practices in NSW,” AMA NSW Director Michael Bonning said. “Unfortunately, general practice continues to struggle with decades of underfunding from the previous Coalition government.”
RACGP NSW and ACT chair, Rebekah Hoffman, said the retrospective payroll tax measure would allow more GPS to operate with certainty without facing a huge tax bill that could have “shut them down”.
“We appreciate the very tight budgetary constraints the NSW government is under and know this decision wasn’t taken lightly,” she stated.
To address the pressures on hospitals, the NSW government has also announced $481 million in spending to help hospital emergency departments under pressure. Around $3.4 billion will be poured into upgrading NSW hospitals and health facilities: nearly $1 billion of this will go towards facilities in rural and regional NSW.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics
Government’s rejection of COVID Royal Commission a stark contrast to the UK and NZ
The Albanese government has dismissed the Senate legal and constitutional committee’s proposal for a COVID-19 pandemic royal commission with one […]
MoreNews & Trends - Biotechnology
AusBiotech and MTPConnect unite for landmark Summit on the nation’s biotech and medtech future
AusBiotech and MTPConnect have announced an ambitious new collaboration to host Australia’s first National Biotech and Medtech Development and Commercialisation […]
MoreNews & Trends - Pharmaceuticals
Targeted therapy with Astellas’ Xtandi improves prostate cancer outcomes for Aussie patients: New study
Pharma News: New research from the led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) […]
More